Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a ...
The newly approved device aims to treat depression by directly stimulating neural activity.
Weill Cornell Medicine investigators have "reverse engineered" ketamine's antidepressant effects to identify potential new ...
New research highlights the growing evidence that cardiovascular fitness and adaptive cognitive training can benefit brain health, potentially lowering risks of dementia, depression, and other ...
A headset recently approved by the Food and Drug Administration uses a weak electric current to shock the brain. Some ...
April 29, 2026 expert reaction to RCT which looks at semaglutide and motivation in depression . A randomised controlled trial published in JAMA Psychiatry looks at semaglutide use ...
Researchers released the first detailed map of smell receptors in the nose, organized into horizontal stripes that mirror the ...
Ahead of his upcoming eight-month stay at the International Space Station, NASA’s Anil Menon discusses how astronauts tackle ...
Interesting Engineering on MSN
FDA clears first US trial of wireless brain implant for treatment-resistant depression
A tiny brain implant, no bigger than a blueberry, is moving from lab concept ...
A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...
A new scientific statement highlights how mental health, sleep, and the gut microbiome shape brain health from childhood ...
Failing to adopt a more inclusive concept of brain health represents a massive loss of human potential,” write Husseini K.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results